This trial is evaluating whether THOR-707 will improve 4 primary outcomes and 11 secondary outcomes in patients with Cancer. Measurement will happen over the course of Study Day 1 until the date of first documented progression or date of death from any cause, assessed up to 24 months.
This trial requires 300 total participants across 4 different treatment groups
This trial involves 4 different treatments. THOR-707 is the primary treatment being studied. Participants will be divided into 4 treatment groups. There is no placebo group. The treatments being tested are in Phase 1 & 2 and have already been tested with other people.
"Overall, the most commonly used treatments for cancer patients were surgery, radiation therapy, and chemotherapy. These were the least common on the list of treatments for other conditions, such as acute lymphocytic leukemia, but were among the first options when a cancer patient was asked for a possible treatment for it. Treatment for cancer is highly dependent on the type of cancer." - Anonymous Online Contributor
"About 4.5 million new cases of cancer are diagnosed each year, making it the most common type of cancer in Americans each year. theme: cancer survivors' health status, cancer patients' mental health, and primary care physicians' attitudes towards patients with cancer, survivorship and quality of life." - Anonymous Online Contributor
"Cancer may have many features: it appears slowly, frequently produces various signs and symptoms, and can be fatal without proper examination and tests. To help you understand cancer, try to imagine the signs of it.\n" - Anonymous Online Contributor
"Cancer is in fact a heterogeneous group of malignant neoplasms. This complexity is reflected in our efforts to select the most commonly used diagnostic techniques. It is not enough to simply state that cancer is "caused" by some environmental and genetic factors, and other factors, for example, lifestyle choices, play an important role in the development of the majority of the neoplasms. All of the factors mentioned above should be considered together to arrive at an integrated concept of carcinogenesis. In this way, the term 'etiology' of cancer can be expanded to include the totality of the information needed to formulate and validate an effective strategy for cancer prevention and treatment." - Anonymous Online Contributor
"Although many tumors can be treated, there are not specific cancer treatments that cure all tumors. More work on improving cancer treatments as a whole, rather than the specific treatment, is now needed." - Anonymous Online Contributor
"Cancer is a disease that is characterized by uncontrolled rapid growth of abnormal cells within a healthy tissue. Cancer causes a wide range of disorders, including but not limited to tissue damage, organ failure, and death." - Anonymous Online Contributor
"These side-effects occurred with almost all patients and may vary with the dosage. In this trial, most of the side effects were mild and most of the reactions were tolerable. The most common reactions included itching. Thor-707-induced itching occurred in a large proportion of patients." - Anonymous Online Contributor
"There is not much difference if the patients take thor-607 or thor-707. Thor-707 showed more improvement of disease severity in patients compared with placebo; but more adverse events happened in patients taking thor-707 compared with patients taking thor-607. A randomized controlled trial with larger and longer follow-up period is needed to clarify if thor-707 may be more effective than thor-607." - Anonymous Online Contributor
"What has progressed in the treatment of solid tumor is remarkable but it is still on a small scale and should it not be that there is more which we have yet to discover and there should not be the fact that we know what we want to know. Even though there’s no one single treatment yet, there are several things which one can try which are not always the same, nevertheless, if they do not bring a better life to the patient, they would never gain anything, only get a lot of pain and maybe even death from cancer. I do think that if this is not enough, then maybe it is time for us to start thinking about the best way to treat the disease which is happening to be cancer." - Anonymous Online Contributor
"In summary, threonine-containing peptides can reduce the amount and development of tumors and prolong survival time. Moreover, these peptides will inhibit the proliferation of tumor cells and inhibit the growth of tumors; thus, it can be regarded as a new chemotherapeutic drug." - Anonymous Online Contributor
"The incidence of cancer increases with age, but, over and above age, more cancer arises in women and/or in people with some type of genetic predisposition for cancer. Thus, the primary underlying cause, if any, of cancer is sex factor. Over and above sex, people who carry genetic risk factors for cancer are at higher risk of developing cancer and are therefore at an increased risk of developing specific types of cancer, such as breast cancer or colorectal cancer, when compared to people without a known predisposing factor for these types of cancer." - Anonymous Online Contributor
"The seriousness of the disease is dependent on the location and type of cancer. Most severe is the case of cancers in the bones, lung, and liver. The prognosis of those types of cancers is generally poor, and they require prompt intervention by surgeons. Those cancers are likely to have spread at the time of diagnosis, and then become harder to cure than those in the rest of the bodies. The prognosis of cancer can be categorized into 4 stages, and these cancers are much better in the early stages of the disease. Stage I, II, and III cancers that have begun growing can be treated to cure them, but a disease has not set in yet, so it cannot be treated." - Anonymous Online Contributor